Scottsdale, AZ – November 3, 2019 – David Schneider, Director of Knowledge Engineering at Systems Imagination (Sister Company of Systems Oncology) spoke about how Systems Imagination uses big data to discover new tiers of medical insights unobtainable through conventional means.
Systems Imagination Presents at Microsoft Ignite 2019
About Systems Oncology
Systems Oncology (SO) combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. These discoveries are then used to better develop truly novel therapeutic agents. SO has the experience and knowhow needed to intelligently translate scientific insights into smarter clinical development strategies and faster registration paths. It then partners with leading pharmaceutical companies to accelerate the development of breakthrough cancer treatments. Fundamental to the SO approach is a next-generation AI platform for translating scientific insights into innovative cancer therapies with unprecedented speed, scale, and precision.